Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Fatigue 5cyclopia sequence 1Sleepiness 1Parasomnias 1Pain 1Lymphoma, B-Cell 1Lung Neoplasms 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Depression 1Central Nervous System Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Brain Neoplasms 1Anorexia 1

Interventions

fludarabine 2Cyclophosphamide 2zanubrutinib 1pegfilgrastim 1obinutuzumab 1fludarabine phosphate 1Specimen Handling 1Resistance Training 1Radiotherapy 1Neuropsychological Tests 1Modafinil 1Magnetic Resonance Spectroscopy 1Lenalidomide 1Injections 1Filgrastim 1Contrast Media 1Blood Specimen Collection 1Azacitidine 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Lymphoma, B-Cell × Modafinil × Clear all
NCT01044004 2013-07-23

Evaluate the Efficacy of Armodafinil for Patients With B-cell Lymphoma and Severe Fatigue

Washington University School of Medicine

Phase NA Withdrawn
Lymphoid

Fatigue, Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡